Literature DB >> 12241021

IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase.

Gerhard Schumann1, Roberto Bonora, Ferruccio Ceriotti, Georges Férard, Carlo A Ferrero, Paul F H Franck, F Javier Gella, Wieland Hoelzel, Poul Jørgen Jørgensen, Takashi Kanno, Art Kessner, Rainer Klauke, Nina Kristiansen, Jean-Marc Lessinger, Thomas P J Linsinger, Hideo Misaki, Mauro Panteghini, Jean Pauwels, Françoise Schiele, Heinz G Schimmel, Gerhard Weidemann, Lothar Siekmann.   

Abstract

This paper is the fourth in a series dealing with reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C and the certification of reference preparations. Other parts deal with: Part 1. The Concept of Reference Procedures for the Measurement of Catalytic Activity Concentrations of Enzymes; Part 2. Reference Procedure for the Measurement of Catalytic Concentration of Creatine Kinase; Part 3. Reference Procedure for the Measurement of Catalytic Concentration of Lactate Dehydrogenase; Part 5. Reference Procedure for the Measurement of Catalytic Concentration of Aspartate Aminotransferase; Part 6. Reference Procedure for the Measurement of Catalytic Concentration of Gamma-Glutamyltransferase; Part 7. Certification of Four Reference Materials for the Determination of Enzymatic Activity of Gamma-Glutamyltransferase, Lactate Dehydrogenase, Alanine Aminotransferase and Creatine Kinase at 37 degrees C. A document describing the determination of preliminary upper reference limits is also in preparation. The procedure described here is deduced from the previously described 30 degrees C IFCC reference method. Differences are tabulated and commented on in Appendix 2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241021     DOI: 10.1515/CCLM.2002.124

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  32 in total

1.  Traceability in clinical enzymology.

Authors:  Ilenia Infusino; Roberto Bonora; Mauro Panteghini
Journal:  Clin Biochem Rev       Date:  2007-11

Review 2.  The de ritis ratio: the test of time.

Authors:  Mona Botros; Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2013-11

3.  Preliminary study of the relationship between promoter methylation of the ANGPTL2 gene and coronary heart disease.

Authors:  Jianqing Zhou; Li Chen; Xi Yang; Xiaoyan Huang; Zicheng Wang; Ping Peng; Jiangfang Lian
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

4.  Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.

Authors:  Eline H van den Berg; Eke G Gruppen; Richard W James; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2018-11-19       Impact factor: 5.922

5.  Effects of electrospun scaffolds of di-O-butyrylchitin and poly-(ε-caprolactone) on wound healing.

Authors:  Jacek Drobnik; Izabella Krucinska; Agnieszka Komisarczyk; Stanislaw Sporny; Alicja Szczepanowska; Joanna Ciosek
Journal:  Can J Surg       Date:  2017-06       Impact factor: 2.089

6.  Agomelatine-induced hepatotoxicity.

Authors:  Matej Štuhec
Journal:  Wien Klin Wochenschr       Date:  2013-03-22       Impact factor: 1.704

7.  Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner.

Authors:  Anje Cauwels; Emmanuel S Buys; Robrecht Thoonen; Lisa Geary; Joris Delanghe; Sruti Shiva; Peter Brouckaert
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

8.  Conus striatus venom exhibits non-hepatotoxic and non-nephrotoxic potent analgesic activity in mice.

Authors:  Rofel Vincent S Jagonia; Rejemae G Dela Victoria; Lydia M Bajo; Roger S Tan
Journal:  Mol Biol Rep       Date:  2019-05-17       Impact factor: 2.316

9.  Clinical study of advanced glycation end products in egyptian diabetic obese and non-obese patients.

Authors:  Mohamed N Amin; Amany A Mosa; Mamdouh M El-Shishtawy
Journal:  Int J Biomed Sci       Date:  2011-09

10.  Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.

Authors:  Danjie Jiang; Dawei Zheng; Lingyan Wang; Yi Huang; Haibo Liu; Leiting Xu; Qi Liao; Panpan Liu; Xinbao Shi; Zhaoyang Wang; Lebo Sun; Qingyun Zhou; Ni Li; Limin Xu; Yanping Le; Meng Ye; Guofeng Shao; Shiwei Duan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.